Regen BioPharma Inc (RGBP)

[Watsonturtle]

This investment will either be off or on. There is no inbetween. Price here is irrelevant because there are so few shares for sale. That's why it's easy for manipulators to walk the price down.

That said: With the NRF26 tech as the catalyst, I have little doubt if those in charge be wanted to sell the company for a huge bump over the current price they could easily do so. That's the value of what you are buying.

But based on the press releases (marketing information) last fall/winter, I think the end game is $2+. If the test data comes in good pre-phase 1, pps will take off like a rocket.

Anybody happen to know (or guess) when the first test data comes in on perfecting the targets for phase 1 clinicals?